SD | MU
“This is an important step forward for patients who have been desperate for evidence-based options,” says Edward Mills, senior author, Professor in McMaster’s Department of Health Research Methods, Evidence, and Impact, and co-principal investigator of the trial. “Fluvoxamine showed consistent and meaningful benefits, and because it’s already widely used and well understood, it has clear potential for clinical use.”